2011-08-31T17:40:43-05:00 2011-03-31 WINDES & MCCLAUGHRY ACCT CORP PO BOX 87 LONG BEACH CA 90801 990 2010-04-01 956043953 ARTHRITIS NATIONAL RESEARCH FOUNDATION ARTH 5624376808 200 OCEANGATE NO 830 LONG BEACH CA 90802 HELENE BELISLE 5624376808 2011-08-31 1 BRIAN D YACKER 5624351191 2010 2016-02-24 21:20:13Z HELENE BELISLE 200 OCEANGATE 830 LONG BEACH CA 90802 3927513 0 X WWW.CUREARTHRITIS.ORG X 1952 CA PROVIDE FINANCIAL SUPPORT FOR: PREVENTION, TREATMENT & CURE OF ARTHRITIS & OTHER RHEUMATIC DISEASES 15 15 2 65 0 0 3040909 2162000 0 0 151307 176624 -2200 -8626 3190016 2329998 921000 975000 0 0 121147 162219 0 0 32761 190026 180297 1232173 1317516 1957843 1012482 5664196 7225335 4846 5446 5659350 7219889 TO FUND PROMISING YOUNG SCIENTISTS AT THE BEGINNING OF THEIR RESEARCH CAREERS TO PURSUE CUTTING-EDGE PROJECTS FOR THE TREATMENT, CURE, AND THE EVENTUAL END TO THE SUFFERING OF OVER 46 MILLION AMERICANS WITH ARTHRITIS AND ITS RELATED DISEASES. 0 0 1058450 975000 MEDICAL RESEARCH GRANTS AWARDED BASED ON GRANT PROPOSALS RECEIVED FROM OUTSIDE INVESTIGATORS WORKING AT INDEPENDENT, UNAFFILIATED RESEARCH FACILITIES AND UNIVERSITIES AND REVIEWED BY INDEPENDENT SCIENTIFIC ADVISORY BOARD AND SCIENTIFIC REVIEW COMMITTEE. ALSO INCLUDES GRANTS FOR PROFESSIONAL MEETING SUPPORT RELATED TO RESEARCH FUNDED. 99449 PROGRAM SERVICE EDUCATION TO RAISE AWARENESS TO MEMBERS OF THE GENERAL PUBLIC AND IN THE MEDICAL PROFESSION REGARDING THE NEED FOR ARTHRITIS RESEARCH FOR A CURE. 1157899 1 1 0 0 0 0 0 0 1 1 0 0 0 0 1 1 0 0 0 0 0 0 0 1 0 0 1 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 1 0 0 1 2 1 0 0 0 0 0 1 1 0 0 X 15 15 0 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 1 0 CA AZ UT VA CT FL WA IL NJ X HELENE BELISLE 5624376808 200 OCEANGATE NO 830 LONG BEACH CA 90802 JAMES ROSE 2.00 X X 0 0 0 MARK SCHULTEN 2.00 X X 0 0 0 VIC BRADEN 1.00 X 0 0 0 KEVIN DONOHUE 1.00 X 0 0 0 KATHRYN S FERRIS 1.00 X 0 0 0 SCOTT GREEN 1.00 X 0 0 0 GALE A GRANGER 3.00 X 0 0 0 MARTI KRUPIN 1.00 X 0 0 0 BRITT L MEYER 1.00 X 0 0 0 LYNN E MOYER 2.00 X 0 0 0 KELLY ROUBA 2.00 X 0 0 0 SHAUN SKERIS 1.00 X 0 0 0 KATHLEEN TEPLEY 1.00 X 0 0 0 MATT WALKER 1.00 X 0 0 0 CARL F WARE 1.00 X 0 0 0 HELENE BELISLE 40.00 X 92750 0 10119 92750 0 10119 0 0 0 0 0 262408 36989 1862603 11600 2162000 122024 122024 1609166 1554566 54600 54600 54600 34323 36989 42949 -8626 -8626 2329998 0 0 167998 975000 975000 93000 65751 16881 10368 44232 35115 3635 5482 13988 10252 2112 1624 10999 8218 1540 1241 14500 14500 19933 19933 9301 8000 1301 1410 1357 53 7517 1414 5695 408 10499 9465 454 580 18077 11651 4998 1428 12049 10907 1142 4401 786 3408 207 ADMINISTRATION 60895 50859 10036 EDUCATION PROGRAM 18860 17698 44 1118 RECOGNITION 1878 1408 254 216 DUES AND SUBSCRIPTIONS 977 877 100 1317516 1157899 126856 32761 117 117 603266 440141 56415 56415 4996384 6720648 8014 8014 5664196 7225335 4846 5446 4846 5446 X 5649064 7209603 10286 10286 5659350 7219889 5664196 7225335 X 1012482 548057 X 1 0 1 X 0 X 764514 892768 2042938 3040909 2162000 8903129 764514 892768 2042938 3040909 2162000 8903129 4243882 4659247 65399 74948 76205 67246 122024 405822 9308951 0.50050 0.80720 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 2063952 504994 -174224 191 2394531 141892 1922060 2063952 141892 141892 0.99570 0.00430 0 0 0 2329998 1317516 1012482 536457 11600 548057 1560539 2886681 536457 536457 2350224 -20226 -20226 2329998 1326142 8626 8626 1317516 0 1317516 DESCRIPTION OF INTENDED USE OF ENDOWMENT FUNDS: PART V, LINE 4: ESTABLISHED AN ENDOWMENT ACCOUNT IN FISCAL 2007-08 AND ONLY ONE CONTRIBUTION TO DATE HAS BEEN DESIGNATED SPECIFICALLY TO THE ENDOWMENT ACCOUNT. THE BOARD OF DIRECTORS CAN AND HAS MADE THE DECISION TO ADD UNRESTRICTED FUNDS TO THE ENDOWMENT FUND IN ORDER TO GROW THIS FUND SO THAT FUTURE INCOME EARNED MAY BE USED FOR GRANT AWARDS AND ORGANIZATION OPERATIONS, IF NECESSARY. THE ENDOWMENT ACCOUNT IS MANAGED BY MEMBERS OF THE BOARD OF DIRECTORS' FINANCE COMMITTEE. DESCRIPTION OF UNCERTAIN TAX POSITIONS UNDER FIN 48: PART X: THE FOUNDATION RECOGNIZES THE FINANCIAL STATEMENT BENEFIT OF TAX POSITIONS, SUCH AS ITS FILING STATUS AS TAX-EXEMPT, ONLY AFTER DETERMINING THAT THE RELEVANT TAX AUTHORITY WOULD MORE LIKELY THAN NOT SUSTAIN THE POSITION FOLLOWING AN AUDIT. THE FOUNDATION IS SUBJECT TO POTENTIAL INCOME TAX AUDITS ON OPEN TAX YEARS BY ANY TAXING JURISDICTION IN WHICH IT OPERATES. THE STATUTE OF LIMITATIONS FOR FEDERAL PURPOSES IS THREE YEARS AND FOR CALIFORNIA PURPOSES IS FOUR YEARS. PART XI, LINE 8 - OTHER ADJUSTMENTS: SPECIAL EVENT IN KIND GIFTS 11,600. PART XII, LINE 4B - OTHER ADJUSTMENTS: SPECIAL EVENT EXPENSE -20,226. PART XIII, LINE 2D - OTHER ADJUSTMENTS: SPECIAL EVENTS 8,626. GOLF TOURNAMENT 55100 20777 34323 3331 4956 7159 18877 MARATHON FOR A CURE 16212 16212 8626 71312 36989 34323 3331 4956 7159 27503 42949 -8626 1 UNIVERSITY OF CALIFORNIA SAN DIEGO 9500 GILMAN DRIVE MC 0602 LA JOLLA CA 92093 75000 RESEARCH ROLE OF INFLAMMASOMEDEPENDENT CYTOKINES IN AUTOINFLAMMATORY DISEASE UNIVERSITY OF VIRGINIA PO BOX 800793 CHARLOTTESVILLE VA 22908 50000 RESEARCH NEW STRATEGIES FOR TREATMENT OF OSTEONECROSIS USING STEM CELLS AND GROWTH FACTORS NEW YORK UNIVERSITY SCHOOL OF MEDICINE 301 EAST 17TH STREET SUITE 1410 NEW YORK NY 10003 75000 RESEARCH 18 FLUORODEOXYGLUCOSE PET AND MRI ASSESSMENT OF ATHEROSCLEROTIC PLAQUE AND THE EFFECTS OF ANTI-TNF THERAPY IN RHEUMATOID ARTHRITIS PATIENTS OKLAHOMA MEDICAL RESEARCH FOUNDATION 825 NE 13TH STREET MS 57 OKLAHOMA CITY OK 73104 75000 RESEARCH BIOMECHANICAL STIMULATION OF CARTILAGE ANTIOXIDANT FUNCTION UNIVERSITY OF COLORADO DENVER 12800 EAST 19TH AVE MAIL STOP 8333 ROOM P18-9119 AURORA CO 80045 50000 RESEARCH THE ROLE OF ARGINASE 1 IN ALPHAVIRUS-INDUCED ARTHRITIS, TENOSYNOVITIS, AND MYOSITIS BROWN MEDICAL SCHOOLRIH CORO WEST 402A 1 HOPPIN ST PROVIDENCE RI 02903 75000 INDUCIBLE DELETION OF IHH PREVENTS OSTEOARTHRITIC CARTILAGE DEGENERATION DEPARTMENT OF PATHOLOGY HARVARD MEDICAL SCHOOL 77 AVENUE LOUIS PASTEUR BOSTON MA 02115 75000 IDENTIFICATION OF THE ROLE OF COMMENSAL BACTERIA AND COMMENSALMEDIATED IMMUNOREGULATION IN AUTOIMMUNE ARTHRITIS UCLA DIV OF REHUMATOLOGY 1000 VETERAN AVE REHAB CTR 32-59 LOS ANGELES CA 900951670 75000 RESEARCH THE ROLE OF COMPLEMENT FACTOR H GENE POLYMORPHISMS IN RISK FOR SLE CLEVELAND CLINIC 9500 EUCLID AVENUE CLEVELAND OH 44195 50000 COLLABORATIVE GRANT WITH NATIONAL PSORIASIS FOUNDATION SAINT LOUIS UNIVERSITY 3556 CAROLINE MALL RM 120 ST LOUIS MO 63104 75000 RESEARCHED ROLE IN ADOPTIVELY TRANSFERRING GPI-SPECIFIC REGULATORY T CELLS TO TREAT THE EFFECTOR PHASE OF RHEUMATOID ARTHRITIS THE SCRIPPS RESEARCH INSTITUTE 10550 NORTH TORREY PINES RD MEM 161 161 LA JOLLA CA 92037 75000 RESEARCH ROLE OF CARTILAGE-SPECFIC MICRORNA IN OSTEOARTHRITIS PATHOGENSIS. UNIVERSITY OF ARIZONA 1501 N CAMPBELL AVE TUSCON AZ 85724 75000 RESEARCH ROLE IN THE CHARACTERIZATION OF PATHOGENIC TH17 RESPONSES IN COLLAGEN INDUCED ARTHRITIS. UCLA 1000 VETERAN AVE REHABILITATION CTR 32-59 LOS ANGELES CA 90095 75000 PROGRAMMED DEATH-1-PROGRAMMED DEATH1LIGAND (PD-1-PDL-1) PATHWAY IN THE NEW ZEALAND BLACK X NEW ZEALAND WHITE (BWF1) MURINE MODEL: A MOLECULAR APPROACH NEW YORK UNIVERSITY SCHOOL OF MEDICINE 540 FIRST AVE SKI 2-17 NEW YORK NY 10016 75000 STUDIES OF THE ROLES OF IL-23 AND IL-22 IN ARTHRITOGENIC TH17 CELL RESONSES AND THE PATHOGENESIS OF AUTOIMMUNE ARTHRITIS. 14 0 PROCEDURE FOR MONITORING GRANTS IN THE U.S.: PART I, LINE 2: SCHEDULE I, PART I, LINE 2: IN MID-JANUARY EACH YEAR, THE ANRF OFFICE RECEIVES GRANT APPLICATIONS FROM SCIENTISTS ACROSS THE COUNTRY, APPROXIMATELY 60-70 PER YEAR. THESE APPLICATIONS MUST FOLLOW THE PUBLISHED GRANT GUIDELINES AND POLICIES ESTABLISHED BY ANRF. THE SCIENTIFIC ADVISORY BOARD (SAB) CONDUCTS AN NIH-LEVEL REVIEW PROCESS PRIOR TO A REVIEW MEETING SESSION HELD IN MARCH OR APRIL (THE DATE VARIES FROM YEAR TO YEAR, DEPENDING ON THE SCHEDULES OF THE MEMBERS). AT THIS REVIEW MEETING, THE SAB ARRIVES AT A RANKING FOR THE APPLICANTS. THIS RANKING IS PRESENTED AT THE REGULAR BOARD OF DIRECTORS MEETING, GENERALLY HELD WITHIN A COUPLE WEEKS OF THE SAB REVIEW MEETING. AT THIS BOARD MEETING, MEMBERS REVIEW AND VOTE ON THE ANNUAL BUDGET, INCLUDING THE TOTAL OF GRANT AWARDS FOR THE YEAR, BASED ON THE RANKING AND RECOMMENDATIONS FROM THE SAB. ANRF'S LARGEST ANNUAL EXPENSE IS THE CUMULATIVE TOTAL OF RESEARCH GRANT AWARDS. GRANTS ARE PAID IN TWO INSTALLMENTS (50% EACH INSTALLMENT) OVER THE COURSE OF THE FISCAL YEAR. THE FIRST PAYMENT OCCURS ON OR BEFORE JUNE 1 WHEN A CHECK FOR 50% OF THE AWARD IS SENT TO THE SCIENTIST'S RESEARCH INSTITUTION. THE SECOND PAYMENT OCCURS IN EARLY MARCH OF THE FOLLOWING YEAR ONCE ANRF HAS RECEIVED A PROGRESS REPORT WHICH IS APPROVED BY THE CHAIR OF THE SCIENTIFIC ADVISORY BOARD. THIS PROGRESS REPORT MUST DEMONSTRATE ADHERENCE TO THE SPECIFIC AIMS OUTLINED IN THE ORIGINAL PROPOSAL AND PROGRESS TOWARD THE GOAL. AT THE END OF THE GRANT AWARD TERM, RECIPIENTS MUST SUBMIT A NARRATIVE, FINAL REPORT, IN WHICH THEY DELINEATE THEIR RESEARCH RESULTS AND ANY PUBLICATIONS OR PUBLIC PRESENTATIONS (GENERALLY AT PROFESSIONAL SCIENTIFIC MEETINGS) THEY HAVE GENERATED AS A RESULT OF THE ANRF GRANT AWARD. DEREK BELISLE SON OF HELENE BELISLE 43000 ADMINISTRATIVE ASSISTANT COMPENSATION 0 FORM 990, PART VI, SECTION B, LINE 11 BOTH THE AUDITED FINANCIAL STATEMENTS AND FORM 990 ARE DISTRIBUTED TO THE MEMBERS OF THE BOARD FOR REVIEW. UPON APPROVAL BY THE BOARD OF DIRECTORS THE EXECUTIVE DIRECTOR SIGNS AND RELEASES THESE DOCUMENTS TO THE PUBLIC AND/OR SUBMITS THE DOCUMENTS TO THE INTERNAL REVENUE SERVICE. FORM 990, PART VI, SECTION B, LINE 12C CONFLICTS OF INTEREST ARE MONITORED CONSTANTLY THROUGH AN ANNUAL WRITTEN CONFIRMATION WHICH IS COMPLETED AND SUBMITTED BY ALL MEMBERS OF THE BOARD OF DIRECTORS. ADDITIONALLY ANY POSSIBLE INDICATION OF CONFLICT OF INTERESTS WHICH ARE BROUGHT TO THE ATTENTION OF THE BOARD, BOARD MEMBERS, SAB MEMBERS OR THE EXECUTIVE DIRECTOR ARE EXAMINED TO DETERMINE WHETHER OR NOT A CONFLICT OF INTEREST EXISTS. THE ORGANIZATION IS VIGILANT IN ITS POLICY TO NOT HAVE ANY HINT OF FAVORTISM OR CONFLICT OF INTEREST. QUESTIONS OF CONFLICT OF INTEREST ARE PLACED BEFORE THE BOARD AT MEETINGS AND REVIEWED PRIOR TO THE MEETING DISCUSSION BY ANRF'S LEGAL COUNSEL. FORM 990, PART VI, SECTION B, LINE 15 FINANCE COMMITTEE USES CURRENT SURVEYS OF EXECUTIVE COMPENSATION AND OTHER FORM 990S TO ASSIST IN DETERMINING COMPENSATION. ACTUAL COMPENSATION RECEIVED IS SUBJECT TO APPROVAL BY THE BOARD OF DIRECTORS AND/OR THE COMPENSATION COMMITTEE. THE EXECUTIVE DIRECTOR IS NOT PRESENT DURING THESE DISCUSSIONS AND APPROVAL MEETINGS. FORM 990, PART VI, SECTION C, LINE 19 ALL REQUESTS FOR THE 990, FORM 1023, AND ORGANIZATIONAL DOCUMENTS SUCH AS FINANCIAL STATEMENTS, CONFLICTS OF INTEREST POLICY, AND GOVERNING DOCUMENTS WILL BE SENT OUT BY REQUEST VIA REGULAR MAIL OR E-MAIL. CHANGES IN NET ASSETS OR FUND BALANCES: FORM 990, PART XI, LINE 5: NET UNREALIZED GAINS ON INVESTMENTS: 536,457. SPECIAL EVENT IN KIND GIFTS 11,600. TOTAL TO FORM 990, PART XI, LINE 5: 548,057. BOARD OF DIRECTORS FORM 990, PART VII HELENE BELISLE IS BOTH THE TOP MANAGEMENT AND TOP FINANCIAL OFFICER WITHIN THE ORGANIZATION. FUNDRAISING EVENTS FORM 990, PART VIII, LINE 8C THE ARTHRITIC NATIONAL RESEARCH FOUNDATION HELD A MARATHON FOR A CURE EVENT. ALL REVENUE RAISED FROMT HE EVENT IS CONSIDERED TO BE CHARITABLE CONTRIBUTIONS. THE ENTITY DOES INCUR EXPENSES IN CONDUCTING THE EVENT, BUT BECAUSE ALL INCOME IS CATEGORIZED AS CONTRIBUTION REVENUE, IT IS REPORTED AS A LOSS FROM SPECIAL EVENTS, EVEN THOUGH THE EVENT WAS PROFITABLE.